Related Experiment Videos
Is there treatment for "genetic" disease?
1McGill University Health Centre, McGill University-Montreal Children's Hospital Research Institute, Montreal, Canada.
Molecular Genetics and Metabolism
|October 21, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Galactose tolerance in adults with classical galactosaemia. Considering the gaps.
Molecular genetics and metabolism reports·2026
Designing rare disease care pathways in the Republic of Ireland: a co-operative model.
Orphanet journal of rare diseases·2022
The natural history of classic galactosemia: lessons from the GalNet registry.
Orphanet journal of rare diseases·2019
Systemic gene dysregulation in classical Galactosaemia: Is there a central mechanism?
Molecular genetics and metabolism·2014
Phenotype variability in six new patients with beta-mannosidosis.
Molecular genetics and metabolism·2026
Global birth prevalence of galactosemia and the role of neonatal screening: A scoping review.
Molecular genetics and metabolism·2026
Hepatoerythropoietic porphyria in a 2-year-old child: Clinical features and effects of treatment.
Molecular genetics and metabolism·2026
Clinical trajectory and long-term management of 3-Hydroxy-3-Methylglutaryl-CoA lyase deficiency: Insights from a lifespan cohort.
Molecular genetics and metabolism·2026
Autonomic and small fiber neuropathy in patients with acute hepatic porphyrias.
Molecular genetics and metabolism·2026
High frequency of the PPOX p.Arg168His pathogenic variant among Brazilian patients with variegate porphyria.
Molecular genetics and metabolism·2026
Distinct neurogenic progenitor cell populations balance cell type production in the embryonic mouse retina.
bioRxiv : the preprint server for biology·2026
Biallelic protein truncating EXOSC6 variants cause a neurodevelopmental disorder with cerebellar atrophy, ataxia, and global developmental delay.
medRxiv : the preprint server for health sciences·2026
Germline NF2 variant position constrains somatic second hits and determines clinical severity in Neurofibromatosis Type 2-related schwannomatosis.
medRxiv : the preprint server for health sciences·2026